Ralimetinib (LY2228820) dimesylate
Ralimetinib (LY2228820) dimesylate is a novel and potent inhibitor of p38 MAPK with IC50 of 7 nM in a cell-free assay, does not alter p38 MAPK activation. Phase 1/2.
| Trivial name | N/A |
| Catalog Number | S1494 |
| Molecular Formula | C20H19ClN6O2 |
| CAS# | 862507-23-1 |
| SMILES | COC(=O)C1=CC2=C(C=C1)N=C(N2)C3CCN(CC3)C4=NC=NC5=C4C(=CN5)Cl |
| Size | 5mg |
| Supplier Page | http://www.selleckchem.com/products/LY2228820.html |
| Additional Information | https://file.selleck.cn/downloads/struct/LY2228820-chemical-structure-S1494.gif |